Trials / Completed
CompletedNCT00370747
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
Efficacy and Safety of Ecabet Ophthalmic Solution for the Treatment of Dry Eye Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 162 (planned)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ecabet | ophthalmic solution 2.83% |
| DRUG | Ecabet | ophthalmic solution 3.70% |
| DRUG | Placebo |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2006-09-01
- Last updated
- 2013-03-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00370747. Inclusion in this directory is not an endorsement.